146 related articles for article (PubMed ID: 12818809)
21. Comparative study on the different techniques for the preparation of sustained-release hydrophobic matrices of a highly water-soluble drug.
Abd El-Halim SM; Amin MM; El-Gazayerly ON; Abd El-Gawad NA
Drug Discov Ther; 2010 Dec; 4(6):484-92. PubMed ID: 22491314
[TBL] [Abstract][Full Text] [Related]
22. Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids.
Jedinger N; Schrank S; Mohr S; Feichtinger A; Khinast J; Roblegg E
Eur J Pharm Biopharm; 2015 May; 92():83-95. PubMed ID: 25733499
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
Hamdani J; Goole J; Moës AJ; Amighi K
Int J Pharm; 2006 Oct; 323(1-2):86-92. PubMed ID: 16815656
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of the thermal properties of ethylcellulose using differential scanning and quasi-isothermal calorimetric approaches.
Lai HL; Pitt K; Craig DQ
Int J Pharm; 2010 Feb; 386(1-2):178-84. PubMed ID: 19932159
[TBL] [Abstract][Full Text] [Related]
25. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.
Hamza Yel-S; Aburahma MH
Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915
[TBL] [Abstract][Full Text] [Related]
26. Study of thermal behaviour of sugar esters.
Szuts A; Pallagi E; Regdon G; Aigner Z; Szabó-Révész P
Int J Pharm; 2007 May; 336(2):199-207. PubMed ID: 17187947
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism of glyceryl behenates: from the individual compounds to the pharmaceutical excipient.
Pivette P; Faivre V; Brubach JB; Daste G; Ollivon M; Lesieur S
Chem Phys Lipids; 2014 Oct; 183():191-203. PubMed ID: 25062895
[TBL] [Abstract][Full Text] [Related]
28. Correlation between the solid state of lipid coating and release profile of API from hot melt coated microcapsules.
Salar-Behzadi S; Corzo C; Schaden L; Laggner P; Zimmer A
Int J Pharm; 2019 Jun; 565():569-578. PubMed ID: 31100383
[TBL] [Abstract][Full Text] [Related]
29. Preparation in high-shear mixer of sustained-release pellets by melt pelletisation.
Voinovich D; Moneghini M; Perissutti B; Filipovic-Grcic J; Grabnar I
Int J Pharm; 2000 Aug; 203(1-2):235-44. PubMed ID: 10967445
[TBL] [Abstract][Full Text] [Related]
30. The use of quasi-isothermal modulated temperature differential scanning calorimetry for the characterization of slow crystallization processes in lipid-based solid self-emulsifying systems.
Otun SO; Meehan E; Qi S; Craig DQ
Pharm Res; 2015 Apr; 32(4):1316-24. PubMed ID: 25330742
[TBL] [Abstract][Full Text] [Related]
31. Theophylline-loaded compritol microspheres prepared by ultrasound-assisted atomization.
Fini A; Cavallari C; Ospitali F; Gonzalez-Rodriguez ML
J Pharm Sci; 2011 Feb; 100(2):743-57. PubMed ID: 20815082
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
Quinten T; De Beer T; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
[TBL] [Abstract][Full Text] [Related]
34. Hot melt coating technology: influence of Compritol 888 Ato and granule size on chloroquine release.
Faham A; Prinderre P; Piccerelle P; Farah N; Joachim J
Pharmazie; 2000 Jun; 55(6):444-8. PubMed ID: 10907253
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium.
Roberts M; Pulcini L; Mostafa S; Cuppok-Rosiaux Y; Marchaud D
Pharm Dev Technol; 2015 Jun; 20(4):507-12. PubMed ID: 24354893
[TBL] [Abstract][Full Text] [Related]
36. Phase Behavior of Drug-Lipid-Surfactant Ternary Systems toward Understanding the Annealing-Induced Change.
Kushwah V; Gomes Lopes D; Saraf I; Koutsamanis I; Werner B; Zangger K; Roy MC; Bartlett JA; Frericks Schmidt H; Shamblin SL; Laggner P; Paudel A
Mol Pharm; 2022 Feb; 19(2):532-546. PubMed ID: 34958588
[TBL] [Abstract][Full Text] [Related]
37. Sustained release solid lipid matrices processed by hot-melt extrusion (HME).
Vithani K; Maniruzzaman M; Slipper IJ; Mostafa S; Miolane C; Cuppok Y; Marchaud D; Douroumis D
Colloids Surf B Biointerfaces; 2013 Oct; 110():403-10. PubMed ID: 23759381
[TBL] [Abstract][Full Text] [Related]
38. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation.
Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z
Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773
[TBL] [Abstract][Full Text] [Related]
39. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol.
Qi S; Avalle P; Saklatvala R; Craig DQ
Eur J Pharm Biopharm; 2008 May; 69(1):364-71. PubMed ID: 18036792
[TBL] [Abstract][Full Text] [Related]
40. Oscillatory Shear Rheology in Examining the Drug-Polymer Interactions Relevant in Hot Melt Extrusion.
Aho J; Edinger M; Botker J; Baldursdottir S; Rantanen J
J Pharm Sci; 2016 Jan; 105(1):160-7. PubMed ID: 26852851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
